Impact of various body weights and serum creatinine concentrations on the bias and accuracy of the Cockcroft-Gault equation.
about
A Review of the Toxicologic Implications of ObesityDosing of antibacterial agents in obese adults: does one size fit all?Comparison of open-access vancomycin dosing websites.Clinical experience with prophylactic fondaparinux in critically ill patients with moderate to severe renal impairment or renal failure requiring renal replacement therapy.Estimation of glomerular filtration rate in cancer patients with abnormal body composition and relation with carboplatin toxicity.Use of a simplified nomogram to individualize digoxin dosing versus standard dosing practices in patients with heart failure.Population Pharmacokinetics of Cefazolin in Serum and Tissue for Patients with Complicated Skin and Soft Tissue Infections (cSSTI).Functional range of creatinine clearance for renal drug dosing: a practical solution to the controversy of which weight to use in the Cockcroft-Gault equation.Kidney function, endothelial activation and atherosclerosis in black and white Africans with rheumatoid arthritisPreliminary clinical study of the effect of ascorbic acid on colistin-associated nephrotoxicityThe association of elevated trough serum vancomycin concentrations with obesity.Quantification of biological aging in young adults.The 6R's of drug induced nephrotoxicityAn Evaluation of Systemic Vancomycin Dosing in Obese PatientsCreatinine-based equations for the adjustment of drug dosage in an obese population.Universal equation for estimating ideal body weight and body weight at any BMIAppropriateness of Dabigatran and Rivaroxaban Prescribing for Hospital Inpatients.Cockcroft-Gault revisited: New de-liver-ance on recommendations for use in cirrhosisEvaluation of renal function in the elderly, not as easy as it seems: a review.Assessment of renal function in geriatric palliative care patients - comparison of creatinine-based estimation equations.Treatment of CMV infection after allogeneic hematopoietic stem cell transplantation.The use of discharge haemoglobin and NT-proBNP to improve short and long-term outcome prediction in patients with acute heart failure.Association between renal function and chemotherapy-related toxicity in older adults with cancer.Comprehensive Guidance for Antibiotic Dosing in Obese Adults.Monitoring Enoxaparin with Antifactor Xa Levels in Obese Patients.Are Vancomycin Trough Concentrations of 15 to 20 mg/L Associated With Increased Attainment of an AUC/MIC ≥ 400 in Patients With Presumed MRSA Infection?A pilot goal-directed perfusion initiative is associated with less acute kidney injury after cardiac surgery.Critical analysis of valganciclovir dosing and renal function on the development of cytomegalovirus infection in kidney transplantation.No role for patient body weight on renal function assessment for drug dosing.Disagreement in Estimates of Kidney Function for Drug Dosing in Obese Inpatients.Appropriateness of direct oral anticoagulant dosing for venous thromboembolism treatment.The performances of the Cockcroft-Gault, modification of diet in renal disease study and chronic kidney disease epidemiology collaboration equations in predicting gentamicin clearance.Start using a checklist, PRONTO: Recommendation for a standard review process for chemotherapy orders.Remembering the past: creatinine clearance and drug dosage adjustment.Evaluation of Dosing Practices of Rivaroxaban and Dabigatran.Pharmacokinetics of metformin in patients with chronic kidney disease stage 4 and metformin-naïve type 2 diabetes
P2860
Q28082947-3CA72F86-11EC-43CB-ACDD-36396DCB2F6FQ30362353-B3D3F5EF-4F6B-444D-A1F6-EAC0A424E470Q30490223-064A1CFF-83B7-4AC0-9004-6968B316EA8BQ33419371-4608CEC6-738B-431D-9918-BE2687E3165EQ33441867-FEC9C61A-772D-4155-BD6B-A2A0922590A2Q34490600-C1B59311-837C-4AEF-BE11-7A5FADBA054DQ34726196-815DD25D-FF79-4FE8-904B-F880AA172E82Q34767683-E636A325-003A-420A-AF17-2FE8E90CFF31Q35217530-A772C981-F520-444D-B4B9-BE52DD977BD3Q35607925-0579E89D-3B62-4622-B144-D805C8DEA736Q35744137-79CEFD64-AC78-4830-BEC3-9510240D4664Q35910158-9E276A50-F05A-4715-882C-B4D02BCD9212Q36333140-CBAC7B43-E00D-4734-8C0C-BC8CC2B07602Q36405861-F15FF188-A7DA-4AFB-8EAA-926787E7D006Q36802097-AC4ED8F5-7DAE-415E-A193-8F371908CD90Q36827971-7FC7C628-A703-442B-819E-67D01C3CF4C5Q37047110-BF59EC01-8B5F-406E-89CB-9D217CE91431Q37628518-AD0BD2FC-82B4-40A6-A1A3-CC0D96192CE6Q38311718-86F55206-B1EC-4875-826D-96D6C24363A5Q38685223-229E2980-C367-4F65-BA9E-3544784FDD7BQ38797660-04F7B834-7F17-4083-B263-C882EBD921E7Q39010655-86751C4D-0EC3-4474-82A1-276773AE146FQ39179989-F0095F3B-8E66-4220-881F-A64FC893DE15Q40067964-8D998089-1132-45BA-82DF-F2EB75FEC0CDQ40284785-27058188-6619-4840-A212-C3865F52623BQ40716347-3F2684B5-AB67-4131-B125-A8EBD30CA6EBQ41058801-4658DE7B-7127-4CAA-A7B4-8E59BD203ABDQ42271698-182E0C84-C1AA-4E77-AE76-82FF80E10D2EQ47223964-1E1BD7A4-698E-406D-A8A9-974DD1745261Q47618850-C9322146-F2C2-4C1B-AEF8-4C4CB0C981A5Q48152210-35E5329B-1D81-4D7B-8F71-0E605B06FAD8Q51163450-159ECE1B-A8BE-40E7-96F6-E48DB047EEC7Q53125855-3FB748FF-6467-430C-BE76-E00D835F1C15Q54562056-23D196D2-CE1F-4125-AB6F-93D8CF8AC60EQ55371809-ABA73A43-5D30-41A4-A41F-ADD21F5B0EB0Q58741340-F31D65A7-9945-41B7-9971-7F2603AEABEE
P2860
Impact of various body weights and serum creatinine concentrations on the bias and accuracy of the Cockcroft-Gault equation.
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年学术文章
@wuu
2012年学术文章
@zh
2012年学术文章
@zh-cn
2012年学术文章
@zh-hans
2012年学术文章
@zh-my
2012年学术文章
@zh-sg
2012年學術文章
@yue
2012年學術文章
@zh-hant
name
Impact of various body weights ...... the Cockcroft-Gault equation.
@en
Impact of various body weights ...... the Cockcroft-Gault equation.
@nl
type
label
Impact of various body weights ...... the Cockcroft-Gault equation.
@en
Impact of various body weights ...... the Cockcroft-Gault equation.
@nl
prefLabel
Impact of various body weights ...... the Cockcroft-Gault equation.
@en
Impact of various body weights ...... the Cockcroft-Gault equation.
@nl
P2093
P2860
P1433
P1476
Impact of various body weights ...... the Cockcroft-Gault equation.
@en
P2093
Gina M Berg
Kelly N Guhr
Mary A Winter
P2860
P304
P356
10.1002/J.1875-9114.2012.01098.X
P407
P577
2012-05-10T00:00:00Z